Recent Advances In Breast Cancer Treatments
DOI:
https://doi.org/10.47611/jsrhs.v10i4.2123Keywords:
Breast Cancer, Breast Cancer Treatments, Advances in Breast Cancer TreatmentsAbstract
Breast cancer is one of the most deadly cancers. Some of the therapies that target breast cancer include surgery, chemotherapy, hormonal therapy, gene therapy, immunotherapy, and radiation. Newer treatment types introduce new ideas and technologies that are fostering new breast cancer treatments. However, breast cancer is a complex disease that ranges in severity and pathology, thereby making a universal treatment elusive. Current strategies to treat breast cancer involve combining multiple therapies. In this review article, I will describe the evolution of breast cancer treatments and its upward trajectory towards finding a cure.
Downloads
References or Bibliography
Allaire, B. T., Ekwueme, D. U., Guy, G. P., Jr, Li, C., Tangka, F. K., Trivers, K. F., Sabatino, S. A., Rodriguez, J. L., & Trogdon, J. G. (2016). Medical Care Costs of Breast Cancer in Privately Insured Women Aged 18-44 Years. American journal of preventive medicine, 50(2), 270–277. https://doi.org/10.1016/j.amepre.2015.08.035
Álvarez, P., Marchal, J. A., Boulaiz, H., Carrillo, E., Vélez, C., Rodríguez-Serrano, F., … Aranega, A. (2012). 5-Fluorouracil derivatives: a patent review. Expert Opinion on Therapeutic Patents, 22(2), 107–123. doi:10.1517/13543776.2012.661413
American Cancer Society. Cancer Facts and Figures 2021. Atlanta, Ga: American Cancer Society; 2021.
Bange, J., Zwick, E., & Ullrich, A. (2001). Molecular targets for breast cancer therapy and prevention. Nature Medicine, 7(5), 548–552. doi:10.1038/87872
Berg, J. (1984). Clinical implications of risk factors for breast cancer. American Cancer Society Journals. https://doi.org/10.1002/1097-0142(19840201)53:3+<589::AID-CNCR2820531302>3.0.CO;2-T
Bland, K. I., Klimberg, V. S., Copeland, E. M., & Gradishar, W. J. (2018). The breast: Comprehensive malignant diseases (5th ed.). Elsevier. https://doi.org/10.1016/C2014-0-01946-6
Bonadonna, G., Brusamolino, E., Valagussa, P., Rossi, A., Brugnatelli, L., Brambilla, C., De Lena, M., Tancini, G., Bajetta, E., Musumeci, R., & Veronesi, U. (1976). Combination chemotherapy as an adjuvant treatment in operable breast cancer. The New England journal of medicine, 294(8), 405–410. https://doi.org/10.1056/NEJM197602192940801
Clark, D. W., & Palle, K. (2016). Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets. Annals of translational medicine, 4(24), 518. https://doi.org/10.21037/atm.2016.11.82
Drugs@FDA: FDA-Approved Drugs. (n.d.). U.S. Food and Drug Administration. Retrieved August 27, 2021, from https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016979
Drugs@FDA: FDA-Approved Drugs. (1971). U.S. Food and Drug Administration. Retrieved August 27, 2021, from https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=016979
Eckschlager, T., Plch, J., Stiborova, M., & Hrabeta, J. (2017). Histone Deacetylase Inhibitors as Anticancer Drugs. International Journal of Molecular Sciences, 18(7), 1414. doi:10.3390/ijms18071414
Giovannelli, Pia; Di Donato, Marzia; Galasso, Giovanni; Di Zazzo, Erika; Bilancio, Antonio; Migliaccio, Antimo (2018). The Androgen Receptor in Breast Cancer. Frontiers in Endocrinology, 9(), 492–.doi:10.3389/fendo.2018.00492
Gold R. H. (1992). The evolution of mammography. Radiologic clinics of North America, 30(1), 1–19.
Halsted Williams S. M.D. The Results Of The Operations For The Cure of Cancer Of The Breast Performed At The Johns Hopkins Hospital From June, 1889, To January, 1894, Annals of Surgery: July 1894 - Volume 20 - Issue - p 497-555
HER2's Genetic Link to Breast Cancer Spurs Development of New Treatments. (2018, April 11). National Cancer Institute. https://www.cancer.gov/research/progress/discovery/her2
King, M.-C. (2014). "The Race" to Clone BRCA1. Science, 343(6178), 1462–1465. doi:10.1126/science.1251900
Madden, John L. M.D.; Kandalaft, Souheil M.D.*; Bourque, Roche-Andre M.D.*† Modified Radical Mastectomy, Annals of Surgery: May 1972 - Volume 175 - Issue 5 - p 624-634
Marosi, C. (2017). DNA Cross Linking. ScienceDirect. Retrieved August 26, 2021, from https://www.sciencedirect.com/topics/medicine-and-dentistry/dna-cross-linking
Marra, P., Mathew, S., Grigoriadis, A., Wu, Y., Kyle-Cezar, F., Watkins, J., Rashid, M., De Rinaldis, E., Hessey, S., Gazinska, P., Hayday, A., & Tutt, A. (2014). IL15RA drives antagonistic mechanisms of cancer development and immune control in lymphocyte-enriched triple-negative breast cancers. Cancer research, 74(17), 4908–4921. https://doi.org/10.1158/0008-5472.CAN-14-0637
Mayer, C., & Kumar, A. (2021). Brachytherapy. In StatPearls. StatPearls Publishing.
Original NDA and Original BLA Approvals December 1978. (1978, December). U.S. Food and Drug Administration. Retrieved August 27, 2021, from https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=reportsSearch.process&rptName=2&reportSelectMonth=12&reportSelectYear=1978&nav
Original NDA and Original BLA Approvals December 1978. (2021, August 26). Retrieved August 26, 2021, from https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=reportsSearch.process&rptName=2&reportSelectMonth=12&reportSelectYear=1978&nav
Patey, D. H., & Dyson, W. H.,(1948). The prognosis of carcinoma of the breast in relation to the type of operation performed. British journal of cancer, 2(1), 7–13. https://doi.org/10.1038/bjc.1948.2
Peters, A. A., Buchanan, G., Ricciardelli, C., Bianco-Miotto, T., Centenera, M. M., Harris, J. M., Jindal, S., Segara, D., Jia, L., Moore, N. L., Henshall, S. M., Birrell, S. N., Coetzee, G. A., Sutherland, R. L., Butler, L. M., & Tilley, W. D. (2009). Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer. Cancer research, 69(15), 6131–6140. https://doi.org/10.1158/0008-5472.CAN-09-0452
Plesca, M., Bordea, C., El Houcheimi, B., Ichim, E., & Blidaru, A. (2016). Evolution of radical mastectomy for breast cancer. Journal of medicine and life, 9(2), 183–186.
Pusey, W.A. (1905). The Therapeutic Use Of X-Rays Journal of the American Medical Association, XLIV(19), 1496. doi:10.1001/jama.1905.92500460004002
Quirke VM (2017) Tamoxifen from Failed Contraceptive Pill to Best-Selling Breast Cancer Medicine: A Case-Study in Pharmaceutical Innovation. Front. Pharmacol. 8:620. doi: 10.3389/fphar.2017.00620
Rajagopalan, P. T. R., Zhang, Z., McCourt, L., Dwyer, M., Benkovic, S., & Hammes, G. (2002). Interaction of dihydrofolate reductase with methotrexate: Ensemble and single-molecule kinetics. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.172501499
Romero, D. (2019). HDAC inhibitors tested in phase III trial. Nature Reviews Clinical Oncology. doi:10.1038/s41571-019-0224-2
Rosenberg B., Vancamp, L., Trosko, J.e., Mansour, V.H. (1969). Platinum Compounds: a New Class of Potent Antitumour Agents. Nature, 222(5191), 385–386. doi:10.1038/222385a0
Rübe, C. E., Donahue, B. R., Cooper, J. S., Oliai, C., Yu, Y., Doyle, L., … Troicki, F. T. (2013). History of Radiation Oncology. Encyclopedia of Radiation Oncology, 314–325. doi:10.1007/978-3-540-85516-3_441
Siegel, J. (1998, September 25). [Letter to Robert Garnick]. https://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/trasgen092598L.pdf
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., & McGuire, W. L. (1987). Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (New York, N.Y.), 235(4785), 177–182. https://doi.org/10.1126/science.3798106
Published
How to Cite
Issue
Section
Copyright (c) 2022 Alexandra Wasserman; Dr. Evan Wasserman, Raymond Mak
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Copyright holder(s) granted JSR a perpetual, non-exclusive license to distriute & display this article.
